MORPHOSYS AG O.N.
Commented by Stefan Feulner on March 25th, 2021 | 08:19 CET
Evotec, PsyBio Therapeutics, MorphoSys - Milestone in Development!
About 350 million people worldwide live with depression. According to estimates by the World Health Organization (WHO), only one in four sufferers receives adequate treatment. With all its limitations, the Corona Crisis has caused the number of unreported cases to skyrocket exorbitantly, making depression the most significant cause of illness above all. Apart from the prescription of antidepressants, which usually have strong side effects, there are few alternative treatment methods. But now, young biotech companies are stepping up to revolutionize the field of "mental health."
Read
Commented by Carsten Mainitz on March 3rd, 2021 | 07:34 CET
Evotec, Cardiol Therapeutics, MorphoSys - Watch out: Great upside potential here in the short term
In the pandemic, investors have learned that small biotech companies, some still with a start-up character, can be worth billions overnight. BioNTech and CureVac are familiar names from the press. Both are linked by the Corona drug and the fact that they are headquartered in Germany. Two other German companies, Evotec and MorphoSys, have written a good growth story on the stock exchange in recent years: small becomes big! Small is also still the Canadian Cardiol Therapeutics. With the announced dual listing on the US technology exchange Nasdaq, a valuation boost could be imminent.
Read
Commented by Mario Hose on January 17th, 2020 | 13:37 CET
Evotec, Memphasys, MorphoSys - Growth Industry Health
He who is healthy has many desires, he who is ill only one. Companies around the globe deal with diseases and special features of nature in order to treat or cure them. In addition to the widespread disease of cancer, there are also topics that are less talked about, but are also a big market. Developments can be of great importance for investors, physicians and the people affected. It can therefore be worthwhile to deal with the variety of topics.
Read